InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by AGENUS INC. Director active across 1 companies, notably MiNK Therapeutics, Inc.. Aggregated, 2 reports have been published. Total volume traded: €28.9m. The latest transaction was disclosed on 19 October 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€14m1,400,000 shares@ €10.3164100.0% of flow
Common Stock
SEC:0000899243-21-040873·
Ideal exit: 16 Jul 2022 (T+270)
€14m1,400,000 shares@ €10.316427.04% mcap50.0% of flow
Common Stock
SEC:0000899243-21-040873:0·
Ideal exit: 16 Jul 2022 (T+270)
2 of 2 declarations
